| Triple negative breast cancer: updates on classification and treatment in 2021 M Bou Zerdan, T Ghorayeb, F Saliba, S Allam, M Bou Zerdan, M Yaghi, ... Cancers 14 (5), 1253, 2022 | 84 | 2022 |
| Breast cancer in the United States: a cross-sectional overview N Bilani, EC Zabor, L Elson, EB Elimimian, Z Nahleh Journal of cancer epidemiology 2020, 2020 | 66 | 2020 |
| Prostate cancer and aspirin use: synopsis of the proposed molecular mechanisms N Bilani, H Bahmad, W Abou-Kheir Frontiers in pharmacology 8, 250576, 2017 | 32 | 2017 |
| Illness cognition and health anxiety in parents of children with cancer N Bilani, S Jamali, A Chahine, M Zorkot, M Homsi, M Saab, R Saab, ... Journal of psychosocial oncology 37 (6), 713-728, 2019 | 31 | 2019 |
| Long-term effect of a nonrandomized psychosocial mindfulness-based intervention in Hispanic/Latina breast cancer survivors E Elimimian, L Elson, N Bilani, SE Farrag, AK Dwivedi, R Pasillas, ... Integrative Cancer Therapies 19, 1534735419890682, 2020 | 28 | 2020 |
| The effect of preoperative pneumonia on postsurgical mortality and morbidity: a NSQIP analysis S Jamali, M Dagher, N Bilani, A Mailhac, M Habbal, S Zeineldine, ... World Journal of Surgery 42 (9), 2763-2772, 2018 | 23 | 2018 |
| Clinical and demographic factors, treatment patterns, and overall survival associated with rare triple-negative breast carcinomas in the US EB Elimimian, TA Samuel, H Liang, L Elson, N Bilani, ZA Nahleh JAMA Network Open 4 (4), e214123-e214123, 2021 | 22 | 2021 |
| Newly-identified pathways relating vitamin D to carcinogenesis: a review N Bilani, L Elson, C Szuchan, E Elimimian, M Saleh, Z Nahleh in vivo 35 (3), 1345-1354, 2021 | 17 | 2021 |
| Male breast cancer: a comparative analysis from the National Cancer Database EB Elimimian, L Elson, H Li, H Liang, N Bilani, EC Zabor, A Statler, ... The World Journal of Men's Health 39 (3), 506, 2021 | 15 | 2021 |
| Effect of surgery at primary and metastatic sites in patients with stage IV breast cancer N Bilani, L Elson, H Liang, EB Elimimian, Z Nahleh Clinical Breast Cancer 21 (3), 170-180, 2021 | 12 | 2021 |
| Precision genetic and genomic medicine in the Middle East and North Africa region: are we there yet? N Bilani, M Dagher, NK Zgheib Public health genomics 20 (3), 149-157, 2017 | 12 | 2017 |
| How we manage systemic immunoglobulin heavy chain amyloidosis (AH amyloidosis) and immunoglobulin heavy-and-light-chain amyloidosis (AH/AL amyloidosis) CP Chaulagain, LC Herlitz, J Fu, N Bilani, C Lucitt, RL Comenzo Clinical Lymphoma Myeloma and Leukemia 20 (11), e826-e831, 2020 | 10 | 2020 |
| Drugs and alcohol themes in recent feature films: A content analysis J El-Khoury, N Bilani, A Abu-Mohammad, R Ghazzaoui, G Kassir, ... Journal of Child & Adolescent Substance Abuse 28 (1), 8-14, 2019 | 10 | 2019 |
| Survival benefit of a combined surgical approach in patients with metastatic breast cancer N Bilani, M Yaghi, I Singh Jabbal, L Elson, EB Elimimian, H Liang, ... Journal of Surgical Oncology 124 (8), 1235-1241, 2021 | 9 | 2021 |
| Metastasectomy versus radiation of secondary sites in stage IV breast cancer: Analysis from a national cancer registry N Bilani, M Yaghi, O Main, M Naik, I Jabbal, C Rivera, L Elson, H Liang, ... The Breast 60, 185-191, 2021 | 7 | 2021 |
| Effect of immunotherapy on overall survival in limited-stage small cell lung carcinoma: a national cancer database analysis N Bilani, E Alley, L Elson, Z Nahleh, R Arteta-Bulos Therapeutic Advances in Medical Oncology 13, 1758835920982806, 2021 | 7 | 2021 |
| Prognostic and predictive value of circulating and disseminated tumor cells in breast cancer: A National Cancer Database (NCDB) analysis N Bilani, L Elson, H Liang, EB Elimimian, R Arteta-Bulos, Z Nahleh Technology in Cancer Research & Treatment 19, 1533033820980107, 2020 | 6 | 2020 |
| Geographical disparities and factors associated with the decision to decline chemotherapy in Breast Cancer IS Jabbal, N Bilani, M Yaghi, L Elson, H Liang, ZA Nahleh JCO Oncology Practice 18 (9), e1417-e1426, 2022 | 5 | 2022 |
| Factors associated with the decision to decline chemotherapy in patients with early-stage, ER+/HER2-breast cancer and high-risk scoring on genomic assays N Bilani, S El Ladki, M Yaghi, O Main, IS Jabbal, L Elson, MB Zerdan, ... Clinical Breast Cancer 22 (4), 367-373, 2022 | 4 | 2022 |
| Advances in the production and application of induced pluripotent stem cells I Mortada, N Bilani Current Stem Cell Research & Therapy 12 (8), 637-643, 2017 | 4 | 2017 |
